News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Popular Diabetes Drug May Lower Prostate Cancer Risk, Harvard School of Public Health Study



1/20/2014 6:53:38 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Higher levels of melatonin, a hormone involved in the sleep-wake cycle, may suggest decreased risk for developing advanced prostate cancer, according to results presented here at the AACR-Prostate Cancer Foundation Conference on Advances in Prostate Cancer Research, held Jan. 18-21. Melatonin is a hormone that is produced exclusively at night in the dark and is an important output of the circadian rhythm, or the body's inherent 24-hour clock.

Hey, check out all the research scientist jobs. Post your resume today!

Read at EurekAlert!
Read at live science
Read at MedicalXpress
Read at News Release
Read at Independent
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES